Interleukin-6 as an emerging regulator of renal cell cancer
详细信息 查看全文
- 作者：Katarzyna Kami艅ska ; Ph.D.a ; kaminska-katarzyna@hotmail.com" class="auth_mail" title="E-mail the corresponding author ; kkaminska@wim.mil.pl" class="auth_mail" title="E-mail the corresponding author ; Anna M. Czarnecka ; Ph.D.a ; Bernard Escudier ; M.D.b ; Fei Lian ; Ph.D.c ; Cezary Szczylik ; M.D. ; Ph.D.a
- 关键词：Renal cancer ; Interleukin-6 ; Metastasis
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2015
- 出版时间：November 2015
- 年：2015
- 卷：33
- 期：11
- 页码：476-485
- 全文大小：1021 K
文摘
- •
IL-6 and its signaling pathways play a crucial role in RCC development.
- •
IL-6 is a potential marker in patients with RCC and is subjected to nephrectomy, quality of life, and treatment.
- •
IL-6 blockade alone or in combination is a promising new therapy for RCC.